Cerebral Hemorrhage
Welcome,         Profile    Billing    Logout  
 11 Companies   13 Products   13 Products   15 Mechanisms of Action   3 Trials   206 News 


1234»
  • ||||||||||  Pneumostem (human umbilical cord blood-derived mesenchymal stem cells) / Medipost, Samsung Medical Center
    Enrollment closed, Trial primary completion date:  Follow-Up Study of Safety of Pneumostem (clinicaltrials.gov) -  Apr 9, 2019   
    P=N/A,  N=9, Active, not recruiting, 
    Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Dec 2018 --> Dec 2022
  • ||||||||||  Enrollment change, Trial withdrawal:  Autologous Umbilical Cord Blood Transfusion for Preterm Neonates (clinicaltrials.gov) -  Feb 12, 2019   
    P1,  N=0, Withdrawn, 
    Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Dec 2018 --> Dec 2022 N=60 --> 0 | Recruiting --> Withdrawn
  • ||||||||||  NN1213 / Novo Nordisk
    Enrollment closed, Trial completion date, Trial primary completion date:  EpoRepair: Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants (clinicaltrials.gov) -  Nov 23, 2018   
    P3,  N=120, Active, not recruiting, 
    Recruiting --> Completed Recruiting --> Active, not recruiting | Trial completion date: Dec 2021 --> Mar 2024 | Trial primary completion date: Feb 2021 --> Dec 2023
  • ||||||||||  NovoSeven (eptacog alfa) / Novo Nordisk
    Trial completion, Trial completion date:  SPOTLIGHT: "Spot Sign" Selection of Intracerebral Hemorrhage to Guide Hemostatic Therapy (clinicaltrials.gov) -  Oct 5, 2018   
    P2,  N=50, Completed, 
    Recruiting --> Active, not recruiting | Trial completion date: Dec 2021 --> Mar 2024 | Trial primary completion date: Feb 2021 --> Dec 2023 Active, not recruiting --> Completed | Trial completion date: Jun 2018 --> Oct 2018
  • ||||||||||  NovoSeven (eptacog alfa) / Novo Nordisk
    Trial completion date, Trial primary completion date:  SPOTLIGHT: "Spot Sign" Selection of Intracerebral Hemorrhage to Guide Hemostatic Therapy (clinicaltrials.gov) -  Jun 2, 2018   
    P2,  N=50, Active, not recruiting, 
    Recruiting --> Completed | N=808 --> 472 Trial completion date: May 2017 --> Jun 2018 | Trial primary completion date: May 2017 --> Jun 2018
  • ||||||||||  PF-05230907 / Pfizer
    Trial completion date, Trial termination, Trial primary completion date:  Safety and Tolerability of PF-05230907 in Intracerebral Hemorrhage (clinicaltrials.gov) -  Feb 13, 2018   
    P1b,  N=21, Terminated, 
    Active, not recruiting --> Terminated | Trial completion date: Jan 2018 --> Jan 2018 | Trial primary completion date: Jan 2018 --> Jan 2018; B2341002 was terminated on 26-OCT-2017 for strategic reasons. The decision to terminate the trial was not based on any safety concerns.
  • ||||||||||  PF-05230907 / Pfizer
    Enrollment closed, Enrollment change, Trial primary completion date:  Safety and Tolerability of PF-05230907 in Intracerebral Hemorrhage (clinicaltrials.gov) -  Dec 19, 2017   
    P1b,  N=21, Active, not recruiting, 
    Recruiting --> Completed | N=50 --> 16 | Trial primary completion date: Dec 2017 --> Sep 2017 Recruiting --> Active, not recruiting | N=36 --> 21 | Trial primary completion date: Jun 2018 --> Jan 2018 | Recruiting --> Active, not recruiting | N=36 --> 21 | Trial primary completion date: Jun 2018 --> Jan 2018 | Recruiting --> Active, not recruiting | N=36 --> 21 | Trial primary completion date: Jun 2018 --> Jan 2018
  • ||||||||||  Trial completion, Enrollment change:  EAPSSP: Electroacupuncture for Poststroke Patients With Shoulder Pain (clinicaltrials.gov) -  Dec 2, 2017   
    P=N/A,  N=45, Completed, 
    Recruiting --> Active, not recruiting | N=36 --> 21 | Trial primary completion date: Jun 2018 --> Jan 2018 | Recruiting --> Active, not recruiting | N=36 --> 21 | Trial primary completion date: Jun 2018 --> Jan 2018 | Recruiting --> Active, not recruiting | N=36 --> 21 | Trial primary completion date: Jun 2018 --> Jan 2018 Recruiting --> Completed | N=60 --> 45
  • ||||||||||  Trial completion, Trial initiation date:  CROMIS-2: Clinical Relevance of Microbleeds In Stroke (clinicaltrials.gov) -  Nov 17, 2017   
    P=N/A,  N=2490, Completed, 
    Recruiting --> Completed | N=60 --> 45 Active, not recruiting --> Completed | Initiation date: Oct 2010 --> Aug 2011
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  LETAP: Optimizing Treatment of Post-hemorrhagic Ventricular Dilation in Preterm Infants (clinicaltrials.gov) -  Nov 7, 2017   
    P2,  N=7, Completed, 
    Active, not recruiting --> Recruiting | Trial primary completion date: Dec 2017 --> Mar 2018 Active, not recruiting --> Completed | N=50 --> 7 | Trial primary completion date: Nov 2016 --> Nov 2013
  • ||||||||||  Enrollment change, Trial initiation date, Trial withdrawal, Trial primary completion date, Intubation:  Early Versus Late Intubation Trial in Physician Manned Emergency Medical Services (clinicaltrials.gov) -  Sep 19, 2017   
    P=N/A,  N=0, Withdrawn, 
    Recruiting --> Completed N=500 --> 0 | Initiation date: Sep 2013 --> Jan 2015 | Suspended --> Withdrawn | Trial primary completion date: Dec 2015 --> Mar 2017
  • ||||||||||  Trial completion, Trial primary completion date:  Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) (clinicaltrials.gov) -  Sep 1, 2017   
    P=N/A,  N=6000, Completed, 
    N=500 --> 0 | Initiation date: Sep 2013 --> Jan 2015 | Suspended --> Withdrawn | Trial primary completion date: Dec 2015 --> Mar 2017 Enrolling by invitation --> Completed | Trial primary completion date: Jun 2016 --> Jul 2017
  • ||||||||||  Enrollment change, Trial termination, Trial primary completion date:  DCC: Delayed Cord Clamping in Very Low Birth Weight Infants (clinicaltrials.gov) -  Aug 29, 2017   
    P=N/A,  N=39, Terminated, 
    Enrolling by invitation --> Completed | Trial primary completion date: Jun 2016 --> Jul 2017 N=300 --> 39 | Active, not recruiting --> Terminated | Trial primary completion date: Aug 2018 --> May 2017; Logistical reasons
  • ||||||||||  Trial completion, Trial initiation date, Trial primary completion date:  MONET: Monitoring Outcome in Neonatal Thrombocytopenia (clinicaltrials.gov) -  Aug 14, 2017   
    P=N/A,  N=700, Completed, 
    N=300 --> 39 | Active, not recruiting --> Terminated | Trial primary completion date: Aug 2018 --> May 2017; Logistical reasons Enrolling by invitation --> Completed | Initiation date: Jan 2015 --> Nov 2015 | Trial primary completion date: Jul 2017 --> Oct 2016
  • ||||||||||  Enrollment closed, Trial primary completion date:  DCC: Delayed Cord Clamping in Very Low Birth Weight Infants (clinicaltrials.gov) -  May 12, 2017   
    P=N/A,  N=300, Active, not recruiting, 
    Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2017 --> Aug 2018
  • ||||||||||  Pneumostem (human umbilical cord blood-derived mesenchymal stem cells) / Medipost, Samsung Medical Center
    Trial completion, Trial primary completion date:  Phase 1 Clinical Trial of PNEUMOSTEM (clinicaltrials.gov) -  Apr 19, 2017   
    P1,  N=9, Completed, 
    Not yet recruiting --> Recruiting Recruiting --> Completed | Trial primary completion date: Dec 2016 --> Feb 2016
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Multimodal Monitoring in Patients With Spontaneous Intracerebral Hemorrhage (clinicaltrials.gov) -  Apr 11, 2017   
    P=N/A,  N=8, Completed, 
    Recruiting --> Completed | Trial primary completion date: Dec 2016 --> Feb 2016 Active, not recruiting --> Completed | N=20 --> 8 | Trial primary completion date: Dec 2016 --> Jun 2016
  • ||||||||||  New trial:  Chongqing Intracerebral Hemorrhage Study (clinicaltrials.gov) -  Mar 21, 2017   
    P=N/A,  N=1000, Recruiting, 
  • ||||||||||  Trial completion:  Placental Transfusion Project for Preterm Infants (clinicaltrials.gov) -  Mar 15, 2017   
    P=N/A,  N=2856, Completed, 
    Active, not recruiting --> Completed | N=20 --> 8 | Trial primary completion date: Dec 2016 --> Jun 2016 Recruiting --> Completed
  • ||||||||||  Trial completion, Trial primary completion date:  Head Position in Stroke Trial (HeadPoST) (clinicaltrials.gov) -  Feb 9, 2017   
    P=N/A,  N=11096, Completed, 
    Trial primary completion date: Dec 2015 --> Jun 2017 Active, not recruiting --> Completed | Trial primary completion date: Aug 2016 --> Dec 2016
  • ||||||||||  NovoSeven (eptacog alfa) / Novo Nordisk
    Trial completion:  FAST: Recombinant Factor VIIa in Acute Intracerebral Haemorrhage (clinicaltrials.gov) -  Jan 11, 2017   
    P3,  N=829, Completed, 
    Enrolling by invitation --> Completed | N=22 --> 14 No longer recruiting --> Completed
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  MNEMONICH: Multinational Survey of Epidemiology, Morbidity, and Outcomes in Intracerebral Hemorrhage (clinicaltrials.gov) -  Dec 9, 2016   
    P=N/A,  N=40, Completed, 
    N=25 --> 1 | Recruiting --> Terminated | Trial primary completion date: Jun 2018 --> Dec 2016 Enrolling by invitation --> Completed | N=10000 --> 40 | Trial primary completion date: Dec 2020 --> Aug 2016